Cross disciplinary and cross industry scientific discoveries occur every day. The American Chemical Society's subsidiary, American Chemical Abstracts, recently made predictions for the expected technological breakthroughs in 2024. This includes new advancements in the accelerated expansion of green chemistry, decarbonization energy, CRISPR clinical validation, the rise of biomaterials, and drug therapy for diseases ranging from cancer to neurodegenerative diseases. The acceleration of artificial intelligence research and development has always been forward-looking in the field of artificial intelligence (AI). Generative artificial intelligence is currently influencing drug discovery, and machine learning is also widely used in environmental research. Large language models like ChatGPT have been tested in healthcare applications and clinical environments. Many scientists are paying attention to alpha folding. This deep thinking company's protein structure prediction software has completely changed the way people understand proteins. Deep Thinking and Isomorphic Laboratories announced earlier that their latest model has shown higher accuracy. In addition, AI driven therapeutic antibody research results are becoming increasingly popular, and platforms such as RubrYc Pharmaceutical's antibody discovery engine are advancing research in this field. Green chemistry promotes environmental protection. Green chemistry is a rapidly developing field. Here, scientists constantly seek innovative methods to minimize the impact of chemical processes on the environment. For example, improving prediction results, reducing plastic usage, searching for alternatives to "endangered elements" in batteries, discovering more sustainable catalysts, and recycling lithium-ion batteries. The rise of biomaterials for biomedical applications may revolutionize many aspects of healthcare by 2024. For example, Neuralink is developing a brain computer interface system that uses a biocompatible electrode network directly implanted into the brain. The system has been approved by the US Food and Drug Administration (FDA) and will begin human trials in 2023. In addition, multifunctional biomaterials and bio inks with biocompatibility and natural sources are cutting-edge technologies worth paying attention to in 2024. The pace of space exploration is relentless. In 2024, NASA plans to launch the Europa Express. It will orbit Jupiter and fly over one of Jupiter's moons, Europa, to study the existence and habitability of water. China's Chang'e-6 mission plans to bring lunar samples back to Earth for further research. The Mars satellite exploration mission of the Japan Aerospace Exploration Agency plans to bring back samples from one of Mars' satellites, Phobos. Boeing is also expected to test fly its reusable spacecraft Starliner, which can take people to near Earth orbit. After years of setbacks and progress, CRISPR therapy has finally been approved for use in humans for the first time. This is a milestone moment for CRISPR technology to unleash its potential to improve human health. In addition to its excellent genome editing capabilities, the biosensing system based on CRISPR Cas has also ushered in a new era of precise early cancer diagnosis. Cancer treatment is advancing rapidly in the field of immunooncology in the past